
- Oncology NEWS International Vol 6 No 5
- Volume 6
- Issue 5
New Neupogen Formula More Temperature Stable
THOUSAND OAKS, Calif--A new formulation of Neupogen (filgrastim or G-CSF) that contains sorbitol instead of mannitol is now available from Amgen.
THOUSAND OAKS, Calif--A new formulation of Neupogen (filgrastim or G-CSF)that contains sorbitol instead of mannitol is now available from Amgen.
The new formulation has the same clinical safety and efficacy profileas the mannitol-containing version, but offers additional flexibility withrespect to storage parameters.
Sorbitol-containing Neupogen will remain stable even if exposed to freezingtemperatures, as might occur in transit. The recommended storage temperaturewill continue to be 2° to 8° C. However, the gel tray insulationand freeze watch indicators required with mannitol-containing Neupogenwill be eliminated, allowing for smaller packaging and reduced need forrefrigerator inventory space.
Articles in this issue
over 28 years ago
Delaying Chemotherapy May Compromise Distant Controlover 28 years ago
Precision Dosing a Reality with Intensity Modulated RTover 28 years ago
Breast Cancer Guide on CD-ROM Is Availableover 28 years ago
Mammography's Predictive Value May Be Improvedover 28 years ago
Oncology Administrators Must Plan for Transition in Mergersover 28 years ago
Differentiation Agent Improves Myelodysplasia Survival Ratesover 28 years ago
NCPB Hears From Several Cancer Groups on Policy Issuesover 28 years ago
Guidelines Needed for Distress in Cancer Patientsover 28 years ago
Skin Cancer Project Receives Recognitionover 28 years ago
Few Patients Surveyed Regret Prophylactic MastectomyNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.